These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 12136429

  • 1. Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression.
    Zhou JH, Rosser CJ, Tanaka M, Yang M, Baranov E, Hoffman RM, Benedict WF.
    Cancer Gene Ther; 2002 Aug; 9(8):681-6. PubMed ID: 12136429
    [Abstract] [Full Text] [Related]

  • 2. GFP image analysis in the mouse orthotopic bladder cancer model.
    De Velasco MA, Tanaka M, Anai S, Tomioka A, Nishio K, Uemura H.
    Oncol Rep; 2008 Sep; 20(3):543-7. PubMed ID: 18695904
    [Abstract] [Full Text] [Related]

  • 3. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q, Mahendran R, Esuvaranathan K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.
    Cancer Res; 2008 Jun 15; 68(12):4506-10. PubMed ID: 18559493
    [Abstract] [Full Text] [Related]

  • 5. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors].
    Wu YD, Tan WL, Xie Y, Yu ZC, Zhao GZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr 15; 26(4):436-40. PubMed ID: 16624746
    [Abstract] [Full Text] [Related]

  • 6. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T, Kawashima T, Kagawa S, Teraishi F, Taki M, Nishizaki M, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T.
    Cancer Res; 2004 Sep 01; 64(17):6259-65. PubMed ID: 15342413
    [Abstract] [Full Text] [Related]

  • 7. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [Abstract] [Full Text] [Related]

  • 8. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI.
    Clin Cancer Res; 2008 Mar 01; 14(5):1510-8. PubMed ID: 18316576
    [Abstract] [Full Text] [Related]

  • 9. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
    Watanabe T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T, Takiguchi M, Hashimoto A, Kuzumaki N, Yamashita M, Tanaka M, Grossman HB, Benedict WF.
    Cancer Gene Ther; 2000 Dec 01; 7(12):1575-80. PubMed ID: 11228536
    [Abstract] [Full Text] [Related]

  • 10. [Effect of mouse uroplakin II promoter on human bladder cancer cell line].
    Zhu HJ, Zhang ZQ, Zeng XF, Wei SS, Xu CX, Huang GJ, Guo YL.
    Zhonghua Zhong Liu Za Zhi; 2004 Jan 01; 26(1):22-5. PubMed ID: 15059347
    [Abstract] [Full Text] [Related]

  • 11. Imaging tumor angiogenesis with fluorescent proteins.
    Hoffman RM.
    APMIS; 2004 Jan 01; 112(7-8):441-9. PubMed ID: 15563308
    [Abstract] [Full Text] [Related]

  • 12. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
    Zang Z, Mahendran R, Wu Q, Yong T, Esuvaranathan K.
    Int J Mol Med; 2004 Oct 01; 14(4):713-7. PubMed ID: 15375606
    [Abstract] [Full Text] [Related]

  • 13. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
    Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI.
    BJU Int; 2008 Aug 05; 102(5):610-6. PubMed ID: 18384625
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.
    Tao Z, Connor RJ, Ashoori F, Dinney CP, Munsell M, Philopena JA, Benedict WF.
    Cancer Gene Ther; 2006 Feb 05; 13(2):125-30. PubMed ID: 16082384
    [Abstract] [Full Text] [Related]

  • 15. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
    Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI.
    BJU Int; 2007 Dec 05; 100(6):1377-84. PubMed ID: 17850390
    [Abstract] [Full Text] [Related]

  • 16. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
    Pasanen T, Hakkarainen T, Timonen P, Parkkinen J, Tenhunen A, Loimas S, Wahlfors J.
    Int J Mol Med; 2003 Oct 05; 12(4):525-31. PubMed ID: 12964030
    [Abstract] [Full Text] [Related]

  • 17. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C, Yan RP, Yuan GH, Feng YG, Wang JS, Gao X, Huang YS, Zhou JB, Xie SS.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 05; 28(10):733-6. PubMed ID: 17366782
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Oct 05; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 19. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, Huwyler J, Missiaen L, de Witte PA.
    J Natl Cancer Inst; 2004 Nov 03; 96(21):1620-30. PubMed ID: 15523091
    [Abstract] [Full Text] [Related]

  • 20. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
    Yang M, Burton DW, Geller J, Hillegonds DJ, Hastings RH, Deftos LJ, Hoffman RM.
    Clin Cancer Res; 2006 Apr 15; 12(8):2602-6. PubMed ID: 16638872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.